Chemotherapeutic Agents Increase the Risk for Pulmonary Function Test Abnormalities in Patients With Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2012.06.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Value of Novel Agents and Intensive Therapy for Patients With Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2013English

Perioperative Complications in Patients With Anthracycline Chemotherapeutic Agents

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
1985English

Front-Line Therapies for Elderly Patients With Transplant-Ineligible Multiple Myeloma and High-Risk Cytogenetics in the Era of Novel Agents

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

Chromosome 1 Abnormalities in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Therapies

Haematologica
Hematology
2014English

Somatostatin Receptor Scintigraphy Might Be Useful for Detecting Skeleton Abnormalities in Patients With Multiple Myeloma and Plasmacytoma

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2009English

Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India

Asian Pacific Journal of Cancer Prevention
2019English

Infections in Hospitalised Patients With Multiple Myeloma: Main Characteristics and Risk Factors

Turkish Journal of Haematology
Hematology
2015English

A High-Risk Signature for Patients With Multiple Myeloma Established From the Molecular Classification of Human Myeloma Cell Lines

Haematologica
Hematology
2010English

Methodology of a Novel Risk Stratification Algorithm for Patients With Multiple Myeloma in the Relapsed Setting

Oncology and Therapy
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy